Enlivex Therapeutics
ENLV
ENLV
4 hedge funds and large institutions have $1.91M invested in Enlivex Therapeutics in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
Holders
4
Holders Change
-4
Holders Change %
-50%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$1.77M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$61K |
3 |
SPIA
3
Steward Partners Investment Advisory
New York
|
$8K |
Top Sellers
1 |
1
Jane Street
New York
|
$64K |
2 |
CH
2
CVI Holdings
Wilmington,
Delaware
|
$0 |
3 |
SM
3
Sabby Management
Miami Beach,
Florida
|
$0 |
4 |
4
Two Sigma Investments
New York
|
$0 |
5 |
5
Two Sigma Advisers
New York
|
$0 |